Australia Platelet Rich Plasma Market Size, Share, and COVID-19 Impact Analysis, By Type (Pure PRP, Leukocyte Rich PRP, and Others), By Application (Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery, General Surgery, Orthopedic, Sports Medicine, Dermatology, and Others), and Australia Platelet Rich Plasma Market Insights, Industry Trend, Forecasts to 2035

Australia Platelet Rich Plasma Market Size Insights Forecasts to 2035

• The Australia Platelet Rich Plasma Market Size Was Estimated at USD 6.1 Million in 2024
• The Market Size is Expected to Grow at a CAGR of Around 14.78% from 2025 to 2035
• The Australia Platelet Rich Plasma Market Size is Expected to Reach USD 27.8 Million by 2035

According to a research report published by Spherical Insights & Consulting, The Australia Platelet Rich Plasma Market Size is Anticipated to Reach USD 27.8 Million by 2035, Growing at a CAGR of 14.78% from 2025 to 2035. The platelet rich plasma market in Australia is driven by the growing need for regenerative medicine, an increase in orthopedic and cosmetic treatments, growing awareness of the advantages of platelet-rich plasma (PRP), developments in autologous therapies, and an expanding healthcare infrastructure.

Market Overview

The Australia Platelet Rich Plasma Market consists of three main activities, which include producing autologous plasma with concentrated platelets and preparing it for medical applications that support tissue repair and healing and regenerative processes. PRP provides its services to multiple fields, including orthopedics and sports medicine, cosmetic and aesthetic procedures, dermatology, wound healing and hair restoration because it delivers less intrusive methods that improve cell growth and tissue healing and restoration processes. Australian hospitals, clinics, and specialized therapy centres increasingly use the technology because of its growing adoption.

The Australia Platelet Rich Plasma Market receives support from governmental programs. The Medical Research Future Fund (MRFF) provides over AUD 2 billion for regenerative medicine research, including PRP applications. The R&D Tax Incentive delivers refundable offsets of up to 43.5%, which research organizations use for their clinical trial costs, while NHMRC grants support the clinical trial process to advance PRP therapy development throughout Australia.

The Australia Platelet Rich Plasma Market has developed through the introduction of next-generation PRP and PRF systems, which T-Lab Australia & New Zealand launched for clinical applications in February 2024. Alocuro provides ARTG-listed PRP devices, which enable clinics to achieve high platelet collection rates while creating customized treatment protocols. The combination of ongoing clinical research together with expanding medical applications in orthopedics and, aesthetics and wound care treatment, as well as technology advancements and business expansion, creates substantial prospects for future development.

Report Coverage

This research report categorizes the market for the Australia Platelet Rich Plasma Market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Australia platelet rich plasma market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Australia platelet rich plasma market.

Driving Factors

The platelet rich plasma market in Australia is driven by healthcare professionals who now prefer less invasive regenerative medical treatments for their work in orthopedics, sports medicine, dermatology, and aesthetic procedures. The market experiences growth because people now understand PRP effectively repairs tissues, restores hair, and heals wounds, while clinics and hospitals increase their adoption rate, and government regulations support the technology and PRP preparation system advancements.

Restraining Factors

The platelet rich plasma market in Australia is mostly constrained by the treatment expenses, and equipment prices remain high while insurance coverage stays insufficient and clinical results show unpredictable results. The medical and aesthetic fields face adoption challenges because practitioners lack standardized procedures and the technical knowledge required for these fields.

Market Segmentation

The Australia platelet rich plasma market share is classified into type and application.

• The leukocyte rich PRP segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period.  

The Australia Platelet Rich Plasma Market is segmented by type into pure PRP, leukocyte rich PRP, and Others. Among these, the leukocyte rich PRP segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. Both platelets and white blood cells are present in L-PRP, which improves tissue regeneration, healing, and anti-infective qualities. Compared to pure PRP or other forms, its effectiveness in orthopaedic treatments, wound healing, and cosmetic applications makes it the go-to option in clinics and hospitals, leading to greater acceptance and revenue share.

• The orthopedic segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.  

The Australia Platelet Rich Plasma Market is segmented by application into cosmetic surgery, ophthalmic surgery, neurosurgery, general surgery, orthopedic, sports medicine, dermatology, and others. Among these, the orthopedic segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. This is due to the fact that PRP treatments successfully hasten the recovery of tendons, ligaments, joints, and musculoskeletal ailments. Its highest market share and anticipated rapid growth are driven by an increase in sports-related injuries, an increase in orthopedic clinic use, and greater awareness of minimally invasive regenerative treatments.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Australia Platelet Rich Plasma Market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Avaderm
• Alocuro
• ANZ Traders & Distributors
• CI Med Products
• CSL Limited
• Melbourne Aesthetic Supplies
• Sydney Medical Supplies
• Brisbane Regenerative Therapy Supplies
• Perth PRP Equipment Distributors
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments:

• In April 2025, with its increased platelet concentration capabilities, the ACP MaxTM PRP device represents a technological breakthrough that Australian clinics utilizing Arthrex products can benefit from.

• In February 2025, Australia's T-Lab PRP system was acknowledged as a top PRP platform in international comparative studies, boosting its adoption and clinical repute.

Market Segment

This study forecasts revenue at the Australia, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Australia Platelet Rich Plasma Market based on the below-mentioned segments:

Australia Platelet Rich Plasma Market, By Type

• Pure PRP
• Leukocyte Rich PRP
• Others

Australia Platelet Rich Plasma Market, By Application

• Cosmetic Surgery
• Ophthalmic Surgery
• Neurosurgery
• General Surgery
• Orthopedic
• Sports Medicine
• Dermatology
• Others